Bedside Injection Medialization Laryngoplasty in Immediate Postoperative Patients

Objectives

The morbidity of glottic insufficiency resulting from unilateral vocal fold immobility may significantly compromise postoperative recovery in patients with decreased pulmonary reserve or inability to protect their airway. Injection medialization laryngoplasty is an effective means of treating glottic insufficiency due to unilateral vocal fold immobility. The purpose of this study is to present our experience with bedside transoral injection medialization laryngoplasty in the immediate postoperative period.

Study Design

Case series with chart review.

Setting

Academic tertiary care hospital.

Subjects and Methods

Patient demographics, clinical characteristics, procedural details, and short-term outcome measures of oral intake were recorded in a cohort of 68 patients over 5 years with unilateral vocal cord paralysis who underwent injection medialization as a bedside procedure in the immediate postoperative period.

Results

Mean time to injection was 8.2 days postoperatively. At the time of injection, 40 of 68 patients were nil per os. Seventy percent (28 of 40) had their diet advanced to adequate oral intake within 5 days of injection. Greater than half of the injections (36 of 68) were performed in the intensive care unit. No complications were noted, and all patients in this cohort were able to tolerate the bedside injection.

Conclusion

Bedside injection medialization laryngoplasty in the immediate postoperative period via the transoral approach can be performed in patients, even in the intensive care unit, while on anticoagulation, and may be of benefit for hospitalized patients with unilateral vocal fold immobility. Further studies quantifying improvement in voice and swallowing data are merited.

Giant cell tumor of the larynx: a case of malignant sarcomatous transformation

We report what is to the best of our knowledge the first case of malignant transformation of a giant cell tumor of the larynx. The patient, a 34-year-old man, presented to our tertiary care university teaching hospital where he underwent hemilaryngopharyngectomy with radial forearm free flap reconstruction and 11 of 15 cycles of chemotherapy. He remained disease-free at approximately 6 years and 4 months of follow-up. The patient is decannulated and continues to have a good voice with excellent quality of life to this day. We discuss the patient's clinical course and subsequent treatment within the context of a review of the current literature regarding this disease entity. Our experience demonstrates that giant cell tumor of the larynx may present as a malignant neoplasm without adversely affecting the patient's prognosis when treated aggressively with surgical resection and adjunct chemotherapy.

Considerations for Initial Dosing of Botulinum Toxin in Treatment of Adductor Spasmodic Dysphonia

Objectives

To assess the effect on voice improvement and duration of breathiness based on initial dose of onabotulinum toxin A (BTX-A) in the management of adductor spasmodic dysphonia (SD) and to compare voice outcomes for initial bilaterally injected doses of 1.25 units (group A) vs 2.5 units (group B) of BTX-A.

Study Design

Case series with chart review of patients with adductor SD treated at a tertiary care facility from 1990 to 2011.

Setting

Academic subspecialty laryngology practice.

Methods

Demographic data (age and sex), voice rating, duration of voice improvement, and breathiness were evaluated and compared between groups A and B using the Student t test and χ2 analysis.

Results

Of 478 patients identified, 305 (223 in group A, 82 in group B) patients met inclusion criteria. The average age was 56.2 years in group A and 57.4 years in group B ( P = .5). The female to male ratio was 2.91 for group A vs 3.56 for group B ( P = .61). Good voice outcomes (grade 3 or 4) were reported by 91% of group A patients vs 94% of group B ( P = .75). The average duration of voice improvement was 99.7 days for group A and 108.3 days for group B ( P = .54). The average duration of breathiness was 10.88 days for group A vs 15.42 days for group B ( P = .02).

Conclusion

Patients injected with 1.25 units bilaterally had a statistically significant shorter duration of breathiness without a statistically significant difference in clinical effectiveness or voice outcome. It is therefore recommended that a relatively low initial BTX-A dose be used with subsequent titration to achieve improved voice outcomes.

Audiologic and genetic features of the A3243G mtDNA mutation

BACKGROUND

Mitochondrial mutations have been shown to be responsible for syndromic and nonsyndromic hearing impairment.

AIM

To assess the genotypic-phenotypic correlation of mitochondrial DNA mutations in three generations of a single family.

METHODS

A single family with maternally inherited diabetes and hearing loss was recruited. Genomic DNA was subject to polymerase chain reaction-restriction fragment length polymorphism analysis (ApaI) for A3243G mutation detection and confirmation with direct DNA sequencing. The degree of heteroplasmy for the A3243G mutation in blood DNA samples was quantified. In addition, we reviewed audiological data of A3243G-associated hearing loss cases from the literature to provide details of audiologic features.

RESULTS

Six of 11 family members were recruited. All affected members harbored the A3243G mutation. Four of six members had diabetes. Five of five affected members demonstrated hearing loss ranging from mild to severe. The degree of heteroplasmy ranged from 5.51% to 27.74%.

CONCLUSIONS

Patients with a greater percentage of heteroplasmy have a trend toward more severe phenotypic presentations. Hearing loss is bilateral, sensorineural, and symmetric. The main audiogram shapes found were sloping. Additional studies are necessary to clarify the relationship between degree of heteroplasmy and phenotypic presentation.

High-resolution computed tomography analysis of the frontal sinus ostium: a pilot study

PURPOSE

Identification and exposure of the frontal sinus recess (FSR) during endoscopic sinus surgery (ESS) are challenging due to the variable anatomy, the narrow opening of the frontal sinus ostium (FSO), and the proximity of vital anatomic structures. Hence, a strong understanding of frontal sinus anatomy is required to prevent intracranial entry. Consistent and easily identifiable landmarks and measurements could assist safe entry into the FSO. In this study, we determine the distances from the columella and anterior nasal spine (ANS) to the nasofrontal beak (NFB) and anterior skull base (ASB) using high-resolution computed tomography (HRCT) scans.

METHODS

A radiographic analysis was performed at a tertiary care medical center. Measurements from the ANS to the NFB and ASB, and from the columella to the NFB and ASB were made using sagittal HRCT. Thirty-two HRCT scans were analyzed by three observers, and the mean distances and standard deviations were calculated.

RESULTS

The mean distance from the ANS to the NFB was 52.3±3.4mm in men and 47.7±3.5mm in women (p<0.0001). Mean distance from the ANS to the ASB was 61.8±4.1mm in men and 56.5±4.1mm in women (p<0.0001). Mean distance from the columella to the NFB was 58.9±2.3mm in men and 53.0±3.3mm in women (p<0.0001), and from the columella to the ASB was 67.9±3.7 mm in men and 61.3±4.1mm in women (p<0.0001).

CONCLUSION

While performing FSR exposure in ESS, it is recommended to stay a distance of less than 66.9 mm in men and 60.6mm in women from the columella to minimize intracranial complications.

Mitochondrial DNA mutation screening in an ethnically diverse nonsyndromic deafness cohort

Deafness is a heterogeneous trait with many known genetic and environmental causes. Hereditary hearing loss is an extremely common disorder in the general population. Mutations in mitochondrial DNA (mtDNA) are known to be associated with nonsyndromic deafness (NSD) and syndromic deafness. The objective of this article is to investigate the frequency of common mitochondrial mutations (A1555G, G7444A, and A3243G) in an ethnically diverse cohort of probands with NSD from South Florida. These patients were ascertained at the University of Miami. Polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing methods were used for mutation screening in a cohort of 217 patients with NSD. The frequency of common mitochondrial mutations is 1.84% (4/217) in this cohort. A1555G and G7444A accounted for four patients with NSD. Our mutation frequencies are comparable with those previously reported in other populations, indicating that mutations in mtDNA are an important cause of NSD in our patient cohort.

Initial Dosing of Botox A in Adductor Spasmodic Dysphonia

Objective: 1) Assess effect on voice improvement and duration of breathiness based on initial dose of BotoxA in management of adductor spasmodic dysphonia. 2) Compare voice outcomes for initial bilaterally injected doses of 1.25 units Botox A (Group A) versus 2.5 units (Group B).

Method: A retrospective chart review was undertaken of all adductor spasmodic dysphonia patients treated at a tertiary care facility between 1990 and 2011. Demographic data (age and sex), voice rating, duration of voice improvement, and breathiness were evaluated and compared between Groups A and B using Student’s t test and chi-square analysis.

Results: Of 478 patients identified, 305 (group A: 223; group B: 82) patients met inclusion criteria. The average age of group A was 56.2 years and group B was 57.4 years ( P = .5). The female/male ratio was 2.91 for group A versus 3.56 for group B ( P = .61). Good voice outcomes (grade 3 or 4) were reported by 91% of group A patients versus 94% of group B ( P = .75). The average duration of voice improvement was 99.7 days for group A and 108.3 for group B ( P = .54). The average duration of breathiness was 10.88 days for group A versus 15.42 for group B ( P = .02).

Conclusion: Patients injected with 1.25 units bilaterally had a statistically significant shorter duration period of breathiness without a statistically significant difference in clinical effectiveness or voice outcome. It is therefore recommended that a relatively low initial Botox dose be used with subsequent titration to achieve improved voice outcomes.

Primary sclerosing fibroinflammatory pseudotumor of the maxillary sinus

Inflammatory pseudotumor is a well known but poorly understood pathologic entity. It is associated with an unusual growth of fibrotic tissue admixed with varying amounts of inflammation that displaces and compresses normal anatomic structures, resulting in dysfunction. Pseudotumors have been found in multiple locations-the orbit in particular-but to the best of our knowledge, none has previously been reported as an isolated sinus lesion. We describe a case of primary sclerosing fibroinflammatory pseudotumor of the maxillary sinus that manifested as recurrent unilateral maxillary sinusitis in a 47-year-old woman. The patient was managed with surgery and oral steroids with full resolution of her symptoms. We also review the presentation, diagnosis, and treatment of fibroinflammatory pseudotumors within the context of the current literature.

L-N-Acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss

CONCLUSION

Combination therapy corticosteroids plus an oral antioxidant L-N-acetylcysteine (LNAC) was associated with improved hearing over corticosteroids alone, particularly at the 6-month follow-up and at high frequencies (i.e. 4000 Hz). This is the first report of a beneficial effect of LNAC in sudden idiopathic sensorineural hearing loss (SISNHL).

OBJECTIVE

To determine the association between antioxidant treatment and functional outcomes in SISNHL.

METHODS

This was a case-control study of adult patients with SISNHL, treated with oral prednisone plus intratympanic dexamethasone either alone or in combination with LNAC. The outcome measure was change in pure-tone thresholds at 500-4000 Hz. Hearing recovery was also recorded as the percentage of subjects with final pure-tone threshold average (PTA) within 50% of the difference between the initial value of the affected ear and the value of the unaffected ear. Comparisons were made between combination (corticosteroids plus LNAC) and single (no LNAC use) therapy groups.

RESULTS

At 6 months, the mean PTA improvements were 26.1 dB and 15.1 dB for the combination and single therapy groups, respectively (p = 0.046). Higher gains at 4000 Hz were noted with LNAC use. The percentage of patients with at least 50% recovery was 63% and 35% for the combination and single therapy groups, respectively (p = 0.0319).

Morbidity of Combined Lateral Pharyngoplasty and Midline Glossectomy for Obstructive Sleep Apnea

Objective: 1) Describe the technique of lateral pharyngoplasty and midline glossectomy. 2) Evaluate the morbidity of multilevel sleep surgery involving lateral pharyngoplasty and midline glossectomy for management of obstructive sleep apnea (OSA).

Method: Retrospective chart review of adult patients with polysomnographic evidence of OSA treated at a tertiary care referral center with multilevel sleep surgery involving lateral pharyngoplasty and midline glossectomy between 2009 and 2010. Outcome measures included estimated blood loss, length of hospital stay, and complications during the perioperative and postoperative period.

Results: Thirty-three patients were identified that met inclusion criteria. Estimated blood loss at time of surgery was 144 milliliters. The average hospital stay was 1.4 days with 1.03 days in an intensive care setting. Sixty-one percent of patients required postoperative oxygen and 9.1% required postoperative continuous positive airway pressure therapy. The perioperative complication rate was 3% (1/33). There were 21% (7/33)minor and 0% (0/33) major complications in the immediate postoperative period.

Conclusion: Lateral pharyngoplasty and midline glossectomy are safe procedures that present a minimal risk to the patient. Postoperative complications are marked predominantly by treatable complaints, including odynophagia and minor infections requiring antibiotic therapy.

Outcomes of Combined Pharyngoplasty and Midline Glossectomy

Objective: 1) Discuss the theory of multilevel sleep surgery for obstructive sleep apnea (OSA) management. 2) Evaluate the outcomes of lateral pharyngoplasty and midline glossectomy.

Method: Retrospective chart review of adult patients with polysomnographic evidence of OSA treated at a tertiary care center with multilevel surgery involving lateral pharyngoplasty and midline glossectomy between 2009 and 2010. Outcome measures included change in preoperative and postoperative AHI, RDI, and oxygen nadir. Statistical analysis performed using Wilcoxon rank test.

Results: Thirty-three patients were identified that met inclusion criteria. The mean preoperative BMI was 30.4, and postoperative BMI was 29.1 ( P = .04). The mean decrease in AHI was 12.5 from 32.7 to 20.2 ( P = .027). The mean decrease in RDI was 16.4 from 37.2 to 20.7 ( P = .17). The mean improvement in oxygen nadir was 13% from 63.5 to 76.8 ( P = .09).

Conclusion: Multilevel sleep surgery results in a statistically significant improvement in polysomnographic metrics, such as AHI and RDI, for obstructive sleep apnea.

Cochlear implantation in common forms of genetic deafness

Genetic factors are among the main etiologies of severe to profound hearing loss and may play an important role in cochlear implantation (CI) outcomes. While genes for common forms of deafness have been cloned, efforts to correlate the functional outcome of CIs with a genetic form of deafness carried by the patient have been largely anecdotal to date. It has been suggested that the differences in auditory performance may be explained by differences in the number of surviving spiral ganglion cells, etiology of hearing loss, and other factors. Knowledge of the specific loci and mutations involved in patients who receive cochlear implants may elucidate other factors related to CI performance. In this review article, current knowledge of cochlear implants for hereditary hearing loss will be discussed with an emphasis on relevant clinical genotype-phenotype correlations.

Airway implications of congenital sternal agenesis

Congenital agenesis of the sternum is an extremely unusual malformation rarely encountered by the practicing Otolaryngologist. It typically arises in conjunction with other midline ventral congenital anomalies, including abdominal, diaphragmatic, and cardiac malformations. We report a case series of two patients managed with tracheotomy placement due to prolonged intubation. The first patient was a 63-day-old infant born at 34 weeks gestation with dysmorphic features, cleft lip and palate, and skeletal dysplasia, including absence of the sternum. The second patient was a 31-day-old infant born with ectopic cordis and diaphragmatic hernia. The inadequate closure of the anterior chest wall secondary to manubrium malformation or a variant contributes significantly to a child's inability to generate adequate ventilatory pressures. As a result, airway management must be considered not only to ensure airway patency but also an appropriate physiological environment to allow for adequate air exchange in the lungs.

S255 – Treatment of Complicated and Uncomplicated Preauricular Pits

Objectives

1) To review our experience with complicated and uncomplicated preauricular pits requiring surgical excision. 2) To review relevant embryology, anatomy, and surgical technique.

Methods

A retrospective chart review from 2002 to 2007 was conducted at a tertiary care university hospital to identify patients less than 18 years old undergoing surgical excision of a preauricular pit. Charts were reviewed for patient age, presentation, complications, treatment algorithm, and outcome.

Results

13 patients underwent surgical excision of a preauricular pit. The indication for excision was either recurrent infection or recurrent drainage in all cases. 3 of 13 patients had a pre-surgical complication of the infection, including localized cellulitis of the preauricular skin or infection of the helical cartilage. These patients were treated with a prolonged course of antibiotics prior to surgical excision. All 13 patients were treated with wide surgical excision; in the 3 patients with pre-excision complications, careful attention was paid to meticulous surgical excision of all involved tissue. There were no postoperative complications. No recurrences were noted at up to 3-year follow-up. Parents were satisfied with the cosmetic outcome in all cases.

Conclusions

Preauricular pits are an important entity due to their potential for significant infectious morbidity. Appropriate diagnosis and management with wide local excision, especially in the context of a complicated presentation, can result in excellent cosmesis with minimal risk of recurrence. Relevant embryology, anatomy, and surgical technique will be reviewed.

Adenotonsillar pathology in post-transplant patients

OBJECTIVE/HYPOTHESIS

The purpose of this study is to evaluate the efficacy of adenotonsillar hypertrophy, Epstein-Barr virus (EBV) titers, and flow cytometry in the evaluation of post-transplant lymphoproliferative disease (PTLD) in an at-risk pediatric population and to propose flow cytometry is the most effective means of diagnosis and directed treatment.

STUDY DESIGN/METHODS

The authors conducted a retrospective chart review of all pediatric transplant patients referred for adenotonsillectomy at a tertiary care center between May 2000 and May 2003. Thirteen patients were identified. All tonsils were evaluated for follicular lymphoid hyperplasia and atypical lymphoid cells. Seven of thirteen samples were stained for EBV RNA, and twelve of thirteen samples were tested using flow cytometry. Positive flow cytometry diagnosis was based on the presence of atypical lymphocytes, gene arrangement, or both.

RESULTS

Seven of thirteen (7/13) examined patients were found to have adenotonsillar hypertrophy. Ten of thirteen (10/13) patients had elevated EBV serum titers. Four of thirteen (4/13) patients were found PTLD positive by flow cytometry. Of the four positive patients, all four patients were found to have elevated EBV titers and only two patients had adenotonsillar hypertrophy.

CONCLUSIONS

Adenotonsillar hypertrophy is not a sensitive indicator of PTLD. EBV serum titers are sensitive but nonspecific. Flow cytometry is the most effective diagnostic modality and allows physicians to tailor treatment to specific forms of PTLD.